MEDIFUSION

Pharmaceuticals, namely, prodrugs, protein fusion compounds and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases, cancer, inflammatory diseases, respiratory and infectious diseases, metabolic diseases, blood disorders and autoimmune diseases; Pharmaceutical compounds, namely, prodrugs, protein fusion compounds and chemical derivatives of pharmaceutically active ingredients for the treatment of the aforesaid diseases